Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
Key facts
- Who runs it
- West Virginia University
- Where
- Morgantown, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 4 people enrolled
- Started
- 30 Sept 2019
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Treatments tested
- Deep Brain Simulator
- Record updated
- 28 July 2025
Who can take part
- Age
- 21 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (31)Hide the full registry criteria
Who can take part
- Fulfills current DSM-5 (American Psychiatric Association Diagnostic and statistical manual of mental disorders, 5th ed, 2013) diagnostic criteria for OUD (severe) and at least a 5-year history
- Participants may have comorbid SUD diagnoses at mild, moderate or severe levels, however OUD must be the primary disorder for which the individual is seeking treatment and the other use disorders must occur in the context of relapse
- Failed at least two levels of treatment (outpatient/Comprehensive Opioid Addiction Treatment (COAT), intensive outpatient/intensive COAT, residential, inpatient, Adult Intensive Outpatient Program (AIOP), Dual Diagnosis Unit (DDU), which included buprenorphine/naloxone
- At least two overdose survivals or one overdose survival and one life-threatening infectious disease complication with relapse after treatment (e.g., endocarditis with valve repair/replacement) within the past 1 year
- Family/Social Support/Involvement (as assessed via the Multidimensional Scale of Perceived Social Support)
- Is able to provide informed consent
Who cannot take part
- Diagnosis of acute myocardial infarction or cardiac arrest within the previous 6 months
- Any medical contraindications to undergoing DBS surgery
- History of previous neurosurgery (brain) or head trauma
- History of a neurosurgical ablation procedure
- History of hemorrhagic stroke
- Past or present diagnosis of schizophrenia, psychotic disorder, bipolar disorder, or untreated depression other than one determined to be substance induced (assessed via SCID-5). Any treated depression has to have been in remission for one year
- Cluster A or B Personality Disorders
- Diagnosis of dementia
- History of neurological disorder
- History of suicide attempt
- Parental history of completed suicide
- Abnormal coagulation lab studies or uncontrolled hypertension
- Any current CNS infection or infection with the Human Immunodeficiency Virus (HIV)
- Documentation of MRI abnormality indicative of a neurological condition
- Conditions requiring diathermy
- Any evidence of systemic infection
- Life expectancy of <3 years
- Medical problems requiring intensive medical or diagnostic management
- Baseline assessment on the Hamilton Depression Rating Scale (HAMD) of greater than 17 or increased risk of suicide based upon any positive response on the Columbia Suicide Severity Scale
- Implanted neurostimulators
- Unable to undergo MR-imaging
- Substance abuse treatment mandated by court of law
- Pregnant or planning to become pregnant
- Anticoagulant treatment
- Primary language other than English
Where in United States
- West Virginia University Rockefeller Neuroscience InstituteMorgantown, United States
About the trial
What the trial wants to find out
The purpose of this clinical study is to investigate the safety, tolerability, and feasibility of Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) and ventral internal capsule (VC) for participants with treatment refractory opioid use disorder (OUD) who have cognitive, behavioral, and functional disability. This study will also provide critical information for planning subsequent clinical trials.
The group in the trial
- OUD DBSTreatment being tested
This is a single arm study. Participants will be followed in an inpatient service for two weeks to gather baseline data followed by DBS placement and up to 6 weeks inpatient for clinical stabilization and DBS titration. All participants will then be followed twice a week for 12 weeks in the outpatient setting and then once a week for a total of 52 weeks post-titration.
Treatment: Deep Brain Simulator
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory
- Publications
- Record updated
- 28 July 2025